In This Article:
-
Revenue: $19.4 million in Q1 2025, compared to $25.1 million in Q4 2024 and $22.7 million in Q1 2024.
-
Indium Phosphide Revenue: $3.8 million, primarily from paw and data center applications.
-
Gallium Arsenide Revenue: $6.7 million.
-
Germanium Substrates Revenue: $0.6 million.
-
Raw Material Joint Venture Revenue: $8.3 million.
-
Regional Revenue Distribution: Asia Pacific 83%, Europe 11%, North America 6%.
-
Non-GAAP Gross Margin: Negative 6.1% in Q1 2025, compared to 17.9% in Q4 2024 and 27.3% in Q1 2024.
-
GAAP Gross Margin: 6.4% in Q1 2025, compared to 17.6% in Q4 2024 and 26.9% in Q1 2024.
-
Non-GAAP Operating Expense: $8.5 million in Q1 2025, compared to $10.5 million in Q4 2024 and $8.7 million in Q1 2024.
-
GAAP Operating Expense: $9.0 million in Q1 2025, compared to $10.6 million in Q4 2024 and $9.4 million in Q1 2024.
-
Non-GAAP Operating Loss: $9.6 million in Q1 2025, compared to $5.4 million in Q4 2024 and $2.5 million in Q1 2024.
-
GAAP Operating Loss: $10.3 million in Q1 2025, compared to $6.2 million in Q4 2024 and $3.3 million in Q1 2024.
-
Non-GAAP Net Loss: $8.2 million or $0.19 per share in Q1 2025, compared to $4.3 million or $0.10 per share in Q4 2024.
-
GAAP Net Loss: $8.8 million or $0.20 per share in Q1 2025, compared to $5.1 million or $0.12 per share in Q4 2024.
-
Cash and Cash Equivalents: $38.2 million as of March 31, 2025, up from $33.8 million on December 31, 2024.
-
Depreciation and Amortization: $2.2 million in Q1 2025.
-
Stock Compensation: $0.6 million in Q1 2025.
-
Net Inventory: $80.4 million, down by approximately $4.7 million in Q1 2025.
Release Date: May 01, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Positive Points
-
AXT Inc (NASDAQ:AXTI) reported Q1 2025 revenue slightly above the midpoint of guidance at $19.4 million.
-
Revenue from the Asia Pacific region was strong, accounting for 83% of total revenue.
-
AXT Inc (NASDAQ:AXTI) has a significant backlog of Indium phosphide sales ready to ship once export permits are secured.
-
The company is seeing increased sales of Indium phosphide within China, driven by the data center market.
-
AXT Inc (NASDAQ:AXTI) has a strong position in the Indium phosphide market, holding an estimated 40% to 50% worldwide market share.
Negative Points
-
Non-GAAP gross margin for Q1 2025 was a negative 6.1%, a significant decline from previous quarters.
-
The company faced yield issues with semi-insulating gallium arsenide wafers, impacting gross margins.
-
Trade restrictions on Indium phosphide exports have delayed shipments to customers outside of China.
-
AXT Inc (NASDAQ:AXTI) reported a non-GAAP net loss of $8.2 million for Q1 2025, compared to a smaller loss in previous quarters.
-
The geopolitical environment and trade restrictions are creating challenges for the company's operations and revenue.